Infectious triggers protect from autoimmunity

Seminars in Immunology

Volumn 23, Issue 2, 2011, Pages 122-129

  Zaccone, Paola ^a   Cooke, Anne ^a  

^a Department of Pathology ^*  (United Kingdom)

Author keywords

Autoimmunity; Hygiene hypothesis; Infection; Therapy

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION; NONHUMAN; REVIEW; VIRUS INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; HUMANS; INFECTION;

EID: 79953163959     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2011.01.013     Document Type: Review

References (119)

1. Lehuen A., Diana J., Zaccone P., Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2010, 10:501-513.
2. Allison A.C. Unresponsiveness to self antigens. Lancet 1971, 2:1401-1403.
3. Oldstone M.B. Molecular mimicry immune-mediated F diseases. FASEB J 1998, 12:1255-1265.
4. Weigle W.O. Recent observations and concepts in immunological unresponsiveness and autoimmunity. Clin Exp Immunol 1971, 9:437-447.
5. Weigle W.O. Self-nonself recognition by T and B lymphocytes and their roles in autoimmune phenomena. Arthritis Rheum 1981, 24:1044-1053.
6. Ellis N.M., Kurahara D.K., Vohra H., Mascaro-Blanco A., Erdem G., Adderson E.E., et al. Priming the immune system for heart disease: a perspective on group A streptococci. J Infect Dis 2010, 202:1059-1067.
7. Rayfield E.J., Kelly K.J., Yoon J.W. Rubella virus-induced diabetes in the hamster. Diabetes 1986, 35:1278-1281.
8. Cooke A., Zaccone P., Raine T., Phillips J.M., Dunne D.W. Infection and autoimmunity: are we winning the war, only to lose the peace?. Trends Parasitol 2004, 20:316-321.
9. Dunne D.W., Cooke A. A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol 2005, 5:420-426.
10. Tracy S., Drescher K.M., Jackson J.D., Kim K., Kono K. Enteroviruses, type 1 diabetes and hygiene: a complex relationship. Rev Med Virol 2010, 20:106-116.
11. Cooke A., Tonks P., Jones F.M., O'Shea H., Hutchings P., Fulford A.J., et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 1999, 21:169-176.
12. Cunha-Neto E., Bilate A.M., Hyland K.V., Fonseca S.G., Kalil J., Engman D.M. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 2006, 39:41-54.
13. Cunningham M.W., Antone S.M., Gulizia J.M., McManus B.M., Fischetti V.A., Gauntt C.J. Cytotoxic viral neutralizing antibodies crossreact with streptococcal M. protein enteroviruses human cardiac myosin. Proc Natl Acad Sci USA 1992, 89:1320-1324.
14. Gauntt C.J., Tracy S.M., Chapman N., Wood H.J., Kolbeck P.C., Karaganis A.G., et al. Coxsackievirus-induced chronic myocarditis in murine F models. Eur Heart J 1995, 16(Suppl. O):56-58.
15. Hyland K.V., Leon J.S., Daniels M.D., Giafis N., Woods L.M., Bahk T.J., et al. Modulation of autoimmunity by treatment of an infectious disease. Infect Immun 2007, 75:3641-3650.
16. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch R.L., Neville K.L., et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997, 3:1133-1136.
17. Moudgil K.D., Chang T.T., Eradat H., Chen A.M., Gupta R.S., Brahn E., et al. Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis. J Exp Med 1997, 185:1307-1316.
18. Playfair J.H., Marshall-Clarke S. Induction of red cell autoantibodies in normal mice. Nat New Biol 1973, 243:213-214.
19. Martins T.C., Aguas A.P. A role for CD45RBlow CD38+ T cells and costimulatory pathways of T-cell activation in protection of non-obese diabetic (NOD) mice from diabetes. Immunology 1999, 96:600-605.
20. Zaccone P., Raine T., Sidobre S., Kronenberg M., Mastroeni P., Cooke A. Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. Eur J Immunol 2004, 34:3246-3256.
21. Raine T., Zaccone P., Mastroeni P., Cooke A. Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes. J Immunol 2006, 177:2224-2233.
22. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003, 197:711-723.
23. Eloranta M.L., Franck-Larsson K., Lovgren T., Kalamajski S., Ronnblom A., Rubin K., et al. Type I interferon system activation and association with disease manifestations in systemic sclerosis. Ann Rheum Dis 2010, 69:1396-1402.
24. Henry T., Kirimanjeswara G.S., Ruby T., Jones J.W., Peng K., Perret M., et al. Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections. J Immunol 2010, 184:3755-3767.
25. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J.M., et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci USA 2001, 98:5752-5757.
26. Dikopoulos N., Bertoletti A., Kroger A., Hauser H., Schirmbeck R., Reimann J. Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells. J Immunol 2005, 174:99-109.
27. Levings M.K., Sangregorio R., Galbiati F., Squadrone S., de Waal Malefyt R., Roncarolo M.G. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001, 166:5530-5539.
28. Lee J., Rachmilewitz D., Raz E. Homeostatic effects of TLR9 signaling in experimental colitis. Ann NY Acad Sci 2006, 1072:351-355.
29. Prinz M., Schmidt H., Mildner A., Knobeloch K.P., Hanisch U.K., Raasch J., et al. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 2008, 28:675-686.
30. Yarilina A., DiCarlo E., Ivashkiv L.B. Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J Immunol 2007, 178:2204-2211.
31. Comi G. Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta. Clin Ther 2009, 31:1142-1157.
32. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N Engl J Med 2000, 343:938-952.
33. Campbell I.L., Kay T.W., Oxbrow L., Harrison L.C. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 1991, 87:739-742.
34. Debray-Sachs M., Carnaud C., Boitard C., Cohen H., Gresser I., Bedossa P., et al. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun 1991, 4:237-248.
35. Hartung H.P., Schafer B., van der Meide P.H., Fierz W., Heininger K., Toyka K.V. The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol 1990, 27:247-257.
36. Jacob C.O., van der Meide P.H., McDevitt H.O. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med 1987, 166:798-803.
37. Baxter A.G., Healey D., Cooke A. Mycobacteria precipitate autoimmune rheumatic disease in NOD mice via an adjuvant-like activity. Scand J Immunol 1994, 39:602-606.
38. Bras A., Aguas A.P. Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease. Immunology 1996, 89:20-25.
39. Harada M., Kishimoto Y., Makino S. Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract 1990, 8:85-89.
40. Shinomiya M., Fazle Akbar S.M., Shinomiya H., Onji M. Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol 1999, 117:38-43.
41. Li X., McKinstry K.K., Swain S.L., Dalton D.K. IFN-gamma acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J Immunol 2007, 179:939-949.
42. Zelante T., Fallarino F., Bistoni F., Puccetti P., Romani L. Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host. Microbes Infect 2009, 11:133-141.
43. Grohmann U., Fallarino F., Bianchi R., Orabona C., Vacca C., Fioretti M.C., et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med 2003, 198:153-160.
44. Grohmann U., Fallarino F., Bianchi R., Vacca C., Orabona C., Belladonna M.L., et al. Tryptophan catabolism in nonobese diabetic mice. Adv Exp Med Biol 2003, 527:47-54.
45. Cervi L., MacDonald A.S., Kane C., Dzierszinski F., Pearce E.J. Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J Immunol 2004, 172:2016-2020.
46. Palanivel V., Posey C., Horauf A.M., Solbach W., Piessens W.F., Harn D.A. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp Parasitol 1996, 84:168-177.
47. Pearce E.J., Kane C.M., Sun J., Taylor J.J., McKee A.S., Cervi L. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol Rev 2004, 201:117-126.
48. Velupillai P., Sypek J., Harn D.A. Interleukin-12 and -10 and gamma interferon regulate polyclonal and ligand-specific expansion of murine B-1 cells. Infect Immun 1996, 64:4557-4560.
49. Zaccone P., Fehervari Z., Jones F.M., Sidobre S., Kronenberg M., Dunne D.W., et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003, 33:1439-1449.
50. Jankovic D., Kugler D.G., Sher A. IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol 2010, 3:239-246.
51. Zaccone P., Burton O.T., Gibbs S., Miller N., Jones F.M., Dunne D.W., et al. Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems. J Biomed Biotechnol 2010, 2010:795210.
52. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010, 107:12204-12209.
53. Li M.O., Sanjabi S., Flavell R.A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006, 25:455-471.
54. Walsh K.P., Brady M.T., Finlay C.M., Boon L., Mills K.H. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol 2009, 183:1577-1586.
55. Beriou G., Bradshaw E.M., Lozano E., Costantino C.M., Hastings W.D., Orban T., et al. TGF-beta induces IL-9 production from human Th17 cells. J Immunol 2010, 185:46-54.
56. Noelle R.J., Nowak E.C. Cellular sources and immune functions of interleukin-9. Nat Rev Immunol 2010, 10:683-687.
57. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540-544.
58. Neill D.R., Wong S.H., Bellosi A., Flynn R.J., Daly M., Langford T.K., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
59. Saenz S.A., Noti M., Artis D. Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. Trends Immunol 2010, 31:407-413.
60. Saenz S.A., Siracusa M.C., Perrigoue J.G., Spencer S.P., Urban J.F., Tocker J.E., et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010, 464:1362-1366.
61. Smith K.A., Efstathiou S., Cooke A. Murine gammaherpesvirus-68 infection alters self-antigen presentation and type 1 diabetes onset in NOD mice. J Immunol 2007, 179:7325-7333.
62. Takei I., Asaba Y., Kasatani T., Maruyama T., Watanabe K., Yanagawa T., et al. Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. J Autoimmun 1992, 5:665-673.
63. Isakov N., Feldman M., Segal S. Lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of macrophages yet fails to affect their phagocytic activity. Immunobiology 1982, 162:15-27.
64. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2007, 178:4557-4566.
65. Smith P., Mangan N.E., Walsh C.M., Fallon R.E., McKenzie A.N., van Rooijen N., et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 2007, 178:4557-4566.
66. Burton O.T., Zaccone P., Phillips J.M., De La Pena H., Fehervari M., et al. Roles for TGF-beta and programmed cell death 1 ligand 1 in regulatory T cell expansion and diabetes suppression by zymosan in nonobese diabetic mice. J Immunol 2010, 185:2754-2762.
67. Feary J.R., Venn A.J., Mortimer K., Brown A.P., Hooi D., Falcone F.H., et al. Experimental hookworm infection: a randomized placebo-controlled trial in asthma. Clin Exp Allergy 2010, 40:299-306.
68. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., Stonebraker A.C., et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008, 455:1109-1113.
69. Clements G.B., Galbraith D.N., Taylor K.W. Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995, 346:221-223.
70. Helfand R.F., Gary H.E., Freeman C.Y., Anderson L.J., Pallansch M.A. Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group. J Infect Dis 1995, 172:1206-1211.
71. Richer M.J., Lavallee D.J., Shanina I., Horwitz M.S. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One 2009, 4:e4127.
72. Skarsvik S., Puranen J., Honkanen J., Roivainen M., Ilonen J., Holmberg H., et al. Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes. Diabetes 2006, 55:996-1003.
73. Yoon J.W., Austin M., Onodera T., Notkins A.L. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979, 300:1173-1179.
74. Hiemstra H.S., Schloot N.C., van Veelen P.A., Willemen S.J., Franken K.L., van Rood J.J., et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA 2001, 98:3988-3991.
75. Hirasawa K., Jun H.S., Han H.S., Zhang M.L., Hollenberg M.D., Yoon J.W. Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signalling pathway and subsequent suppression of nitric oxide production in macrophages. J Virol 1999, 73:8541-8548.
76. Tirabassi R.S., Guberski D.L., Blankenhorn E.P., Leif J.H., Woda B.A., Liu Z., et al. Infection with viruses from several families triggers autoimmune diabetes in LEW*1WR1 rats: prevention of diabetes by maternal immunization. Diabetes 2010, 59:110-118.
77. Ward K.P., Galloway W.H., Auchterlonie I.A. Congenital cytomegalovirus infection and diabetes. Lancet 1979, 1:497.
78. Helmke K., Otten A., Willems W. Islet cell antibodies in children with mumps infection. Lancet 1980, 2:211-212.
79. Hyoty H., Hiltunen M., Reunanen A., Leinikki P., Vesikari T., Lounamaa R., et al. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group. Diabetologia 1993, 36:1303-1308.
80. Guberski D.L., Thomas V.A., Shek W.R., Like A.A., Handler E.S., Rossini A.A., et al. Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 1991, 254:1010-1013.
81. Zipris D., Hillebrands J.L., Welsh R.M., Rozing J., Xie J.X., Mordes J.P., et al. Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations. J Immunol 2003, 170:3592-3602.
82. Honeyman M.C., Coulson B.S., Stone N.L., Gellert S.A., Goldwater P.N., Steele C.E., et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000, 49:1319-1324.
83. Honeyman M.C., Stone N.L., Harrison L.C. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol Med 1998, 4:231-239.
84. Onodera T., Jenson A.B., Yoon J.W., Notkins A.L. Virus-induced diabetes mellitus: reovirus infection of pancreatic beta cells in mice. Science 1978, 201:529-531.
85. Ou D., Mitchell L.A., Metzger D.L., Gillam S., Tingle A.J. Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognised by T cells of patients with type I diabetes mellitus. Diabetologia 2000, 43:750-762.
86. Olson J.K., Ercolini A.M., Miller S.D. A virus-induced molecular mimicry model of multiple sclerosis. Curr Top Microbiol Immunol 2005, 296:39-53.
87. Zhao Z.S., Granucci F., Yeh L., Schaffer P.A., Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998, 279:1344-1347.
88. Deshpande S.P., Lee S., Zheng M., Song B., Knipe D., Kapp J.A., et al. Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis. J Virol 2001, 75:3077-3088.
89. La Flamme A.C., Ruddenklau K., Backstrom B.T. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 2003, 71:4996-5004.
90. Nagayama Y., Watanabe K., Niwa M., McLachlan S.M., Rapoport B. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism. J Immunol 2004, 173:2167-2173.
91. Osada Y., Shimizu S., Kumagai T., Yamada S., Kanazawa T. Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators. Int J Parasitol 2009, 39:457-464.
92. Saunders K.A., Raine T., Cooke A., Lawrence C.E. Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun 2007, 75:397-407.
93. Hubner M.P., Stocker J.T., Mitre E. Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology 2009, 127:512-522.
94. Elliott D.E., Setiawan T., Metwali A., Blum A., Urban J.F., Weinstock J.V. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 2004, 34:2690-2698.
95. Graham K.L., O'Donnell J.A., Tan Y., Sanders N., Carrington E.M., Allison J., et al. Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset. J Virol 2007, 81:6446-6458.
96. Harrison L.C. Vaccination against self to prevent autoimmune disease: the type 1 diabetes model. Immunol Cell Biol 2008, 86:139-145.
97. Filippi C.M., Estes E.A., Oldham J.E., von Herrath M.G. mmunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J Clin Invest 2009, 119:1515-1523.
98. Oldstone M.B., Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J Exp Med 1990, 171:2077-2089.
99. Wilberz S., Partke H.J., Dagnaes-Hansen F., Herberg L. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 1991, 34:2-5.
100. Davydova B., Harkonen T., Kaialainen S., Hovi T., Vaarala O., Roivainen M. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice. J Med Virol 2003, 69:510-520.
101. Horwitz M.S., Ilic A., Fine C., Balasa B., Sarvetnick N. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells. Clin Immunol 2004, 110:134-144.
102. Serreze D.V., Ottendorfer E.W., Ellis T.M., Gauntt C.J., Atkinson M.A. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000, 49:708-711.
103. Serreze D.V., Wasserfall C., Ottendorfer E.W., Stalvey M., Pierce M.A., Gauntt C., et al. Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. J Virol 2005, 79:1045-1052.
104. Tracy S., Drescher K.M., Chapman N.M., Kim K.S., Carson S.D., Pirruccello S., et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 2002, 76:12097-12111.
105. Sewell D., Qing Z., Reinke E., Elliot D., Weinstock J., Sandor M., et al. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 2003, 15:59-69.
106. Elliott D.E., Li J., Blum A., Metwali A., Qadir K., Urban J.F., et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003, 284:G385-391.
107. Zaccone P., Burton O., Miller N., Jones F.M., Dunne D.W., Cooke A. Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur J Immunol 2009, 39:1098-1107.
108. Atochina O., Harn D. Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans. Exp Dermatol 2006, 15:461-468.
109. Harn D.A., McDonald J., Atochina O., Da'dara A.A. Modulation of host immune responses by helminth glycans. Immunol Rev 2009, 230:247-257.
110. Goodridge H.S., Marshall F.A., Else K.J., Houston K.M., Egan C., Al-Riyami L., et al. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J Immunol 2005, 174:284-293.
111. McInnes I.B., Leung B.P., Harnett M., Gracie J.A., Liew F.Y., Harnett W. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol 2003, 171:2127-2133.
112. Harnett W., Harnett M.M. Helminth-derived immunomodulators: can understanding the worm produce the pill?. Nat Rev Immunol 2010, 10:278-284.
113. Imai S., Tezuka H., Fujita K. A factor of inducing IgE from a filarial parasite prevents insulin-dependent diabetes mellitus in nonobese diabetic mice. Biochem Biophys Res Commun 2001, 286:1051-1058.
114. Sadelain M.W., Qin H.Y., Lauzon J., Singh B. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 1990, 39:583-589.
115. Toyota T., Satoh J., Oya K., Shintani S., Okano T. Streptococcal preparation (OK-432) inhibits development of type I diabetes in NOD mice. Diabetes 1986, 35:496-499.
116. Sai P., Rivereau A.S. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae. Diab Metab 1996, 22:341-348.
117. Alyanakian M.A., Grela F., Aumeunier A., Chiavaroli C., Gouarin C., Bardel E., et al. Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes 2006, 55:179-185.
118. Pritchard D.I., Todd I., Brown A., Bycroft B.W., Chhabra S.R., Williams P., et al. Alleviation of insulitis and moderation of diabetes in NOD mice following treatment with a synthetic Pseudomonas aeruginosa signal molecule, N-(3-oxododecanoyl)-l-homoserine lactone. Acta Diabetol 2005, 42:119-122.
119. Karumuthil-Melethil S., Perez N., Li R., Vasu C. Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes. J Immunol 2008, 181:8323-8334.